ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 258

Prevalence of Echocardiographic Findings in Connective Tissue Diseases – a Retrospective Cohort Study

Valentin S. Schäfer1, Katharina Weiss2, Andreas Krause2 and Wolfgang A. Schmidt3, 1Immanuel Krankenhaus Berlin, Medical Center for Rheumatology Berlin-Buch, Berlin, Germany, 2Medical Centre for Rheumatology Berlin-Buch, Immanuel Krankenhaus Berlin, Berlin, Germany, 3Medical Center for Rheumatology and Clinical Immunology Berlin-Buch, Immanuel Krankenhaus Berlin, Berlin, Germany

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Connective tissue diseases, Diagnostic imaging, heart disease and ultrasonography

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 5, 2017

Title: Imaging of Rheumatic Diseases Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Echocardiography is frequently performed in patients with connective tissue diseases (CTD), mostly to evaluate cardiac involvement or development of pulmonary arterial hypertension (paH). Despite the application as part of routine clinical follow-up, there is incomplete data for the range and frequency of findings in different CTD.

Methods: We included all consecutive patients from a tertiary rheumatological referral center with CTD diagnosis and echocardiographic examination between January 1st 2006 and December 31st 2015 by retrospective chart review. For each echocardiographic finding, the proportion of patients per diagnosis with a pathological result in at least one examination was calculated. Further, each finding´s frequency in patients with and without previously documented inflammatory cardiac involvement was compared. For patients with more than one visit, we recorded how often findings developed or resolved over time.

 

Results: 1004 patients with different CTD and a total of 1660 performed echocardiographies were identified. Table 1 displays the frequency of findings in the whole cohort and for each CTD, respectively. The most common findings were mitral, aortic and tricuspid regurgitation, aortic valve sclerosis, left ventricular dysfunction, and left atrial dilatation. Table 2 shows which findings were significantly more common in patients with a history of inflammatory cardiac involvement (n=109).  314 patients had consecutive examinations; medium interval between first and last examination was 40 months (SD: 28, range: 0.9-115). Development and regression of findings during follow-up are given in table 3. Mitral (24%) or tricuspid regurgitation (21%), aortic valve sclerosis (18%) and left ventricular dysfunction (20%) most commonly developed.

Conclusion: This study is the first to report echocardiographic findings in a large cohort of different CTD. Abnormal findings are common in all disease entities. Some pathological findings are more common in patients having suffered from cardiac involvement, these seem to be disease-related. In follow-up, a change of findings was frequently observed. These results support the role of echocardiography for routine examination and in follow-up in patients with CTD.



Disclosure: V. S. Schäfer, None; K. Weiss, None; A. Krause, None; W. A. Schmidt, None.

To cite this abstract in AMA style:

Schäfer VS, Weiss K, Krause A, Schmidt WA. Prevalence of Echocardiographic Findings in Connective Tissue Diseases – a Retrospective Cohort Study [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/prevalence-of-echocardiographic-findings-in-connective-tissue-diseases-a-retrospective-cohort-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/prevalence-of-echocardiographic-findings-in-connective-tissue-diseases-a-retrospective-cohort-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology